When overwhelmed with stress, cells can enter a zombie-like state called senescence. The build-up of these cells in the brain has been linked to several diseases. Bough Biosciences will develop a novel approach to discover senolytics, drugs that remove senescent cells. We will tailor and develop disease-specific senolytics using single cell-RNA sequencing to build models to understand what causes the build-up of these cells in different diseases. Understanding these features allows us to model disease-specific cellular senescence in a petri dish outside the human body and identify potent compounds specific for the senescent cells in neurological and neuropsychiatric disease.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.